# S2N Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/s2n-health

- Industry: Software
- Headquarters: Boston, US
- Website: www.s2nhealth.com
- Total disclosed funding: $3.1M
- Latest round: Seed (May 10, 2024)
- Investors on record: 3

## About

Established in 2011 and based in Massachusetts, US, S2N Health, Inc. operates as a provider of AI-powered market intelligence platform for the healthcare technology sector. The company was founded by its CEO, Amy Siegel, CTO Tim Kofol. In May 2024, S2N Health Inc. raised an amount of USD 3.11 million in seed funding led by Excelerate Health Ventures, Boston Millennia Partners and Robin Hood Ventures. The seed funding values S2N Health, Inc. at USD 5.98 million post-money.

S2N Health provides market intelligence to medtech companies. The company's platform offers data-driven insights designed to assist with new product launches and market share expansion. The company’s product line includes RepSignal, an AI-powered customer intelligence platform designed to align sales and marketing efforts for medtech companies. RepSignal uses a six-step framework, incorporating customer-centric insights, to guide campaigns from planning to execution.

The company plans to utilize the funding raised in May 2024 to boost its growth and accelerate its service features and offerings.

## Funding rounds

- Seed, May 10, 2024, $3.1M — Boston Millennia Partners, Robin Hood Ventures, Excelerate Health Ventures

## Investors

- Boston Millennia Partners (https://capitalatlas.ai/funds/boston-millennia-partners) — Seed
- Robin Hood Ventures (https://capitalatlas.ai/funds/robin-hood-ventures) — Seed
- Excelerate Health Ventures (https://capitalatlas.ai/funds/excelerate-health-ventures) — Seed